[1]涂雅丹 陈勇 方邦江 刘力 任毅.重庆市1200例新型冠状病毒肺炎中医证候特点与临证举隅[J].陕西中医药大学学报,2023,(02):009-14.[doi:10.13424/j.cnki.jsctcm.2023.02.002 ]
　TU Yadan CHEN Yong FANG Bangjiang,REN Yi LIU Li.TCM Syndrome Characteristics and Clinical Examples of 1200 Cases of COVID-19 in Chongqing[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):009-14.[doi:10.13424/j.cnki.jsctcm.2023.02.002 ]
点击复制

重庆市1200例新型冠状病毒肺炎中医证候特点与临证举隅
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2023年02期
页码:
009-14
栏目:
出版日期:
2023-05-13

文章信息/Info

Title:
TCM Syndrome Characteristics and Clinical Examples of 1200 Cases of COVID-19 in Chongqing
文章编号:
2096-1340(2023)02-0009-06
作者:
涂雅丹 1 陈勇 1 方邦江 2; 3; 4 刘力 1 任毅 4
1.重庆市中医院，重庆 400021；
2.上海中医药大学附属龙华医院，上海200032 ；
3．上海中医药大学急危重病研究所，上海 200032；
4．陕西中医药大学疫病防治研究中心，陕西 咸阳 712046
Author(s):
TU Yadan1 CHEN Yong1 FANG Bangjiang2; 3; 4 ;  REN Yi1 LIU Li4
1.Chongqing Hospital of Chinese Medicine,Chongqing 400021,China;
2.Longhua Hospital affiliated to Shanghai University of Chinese Medicine,Shanghai 200032,China;
3.Institute of Acute and Critical Diseases,Shanghai University of Chinese Medicine,Shanghai 200032,China;
4.Epidemic Disease Control Research Center of Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China
关键词:
关键词：新型冠状病毒肺炎; 重庆市; 中医证候; 表里双解; 截断扭转
Keywords:
Key words： COVID-19; Chongqing; TCM syndrome; Both exterior and interior solutions; Truncated torsion
分类号:
R254.2
DOI:
10.13424/j.cnki.jsctcm.2023.02.002
文献标志码:
A
摘要:
摘 要：目的 通过分析2022年重庆市1200例新型冠状病毒感染的肺炎（简称“新冠肺炎”）患者中医临床望、闻、问、切四诊资料，探讨新冠肺炎的中医证候特点及方邦江教授“表里双解”截断扭转法在重庆市新冠肺炎救治中验案举隅。方法 选取2022年11月15日—2022年12月2日收治于石子山方舱医院的1200例新冠肺炎确诊患者。记录患者中医临床症状，舌脉诊资料，分析并总结新冠肺炎患者中医证候特点。结果 在重庆市1200例新冠肺炎患者中，无症状感染者874例（72.83%），轻型患者326例（27.17%）。轻型患者位于前5位的中医症状依次为咳嗽208例（63.80%）、咽干194例（59.51%）、咽痛168例（51.53%）、纳差114例（34.97%）、发热91例（27.91%）。发热体温以低热为主。轻型患者中舌诊以红舌248例（76.07%）、白腻苔196例（60.12%）为主。无症状患者舌诊以淡红舌769例（87.99%），薄黄苔578例（66.13%）为主。轻型患者脉诊以滑数脉168例（5153%）为主，无症状患者脉诊以滑脉 536例（61.33%）为主。结论 重庆市此轮新冠肺炎主要以无症状及轻型患者为主，均符合中医“疫病”之“湿温病”的临床特征，其病机特点为“疫毒挟湿致病”。
Abstract:
Abstract： Objective To explore the characteristics of TCM syndromes of COVID-19 and the examples of Professor FANG Bangjiangs “exterior interior double solution” truncation torsion method in the treatment of COVID-19 in Chongqing by analyzing four methods of diagnosis data of 1200 cases of COVID-19 in Chongqing in 2022.Methods From November 15,2022 to December 2,2022,1200 patients with COVID-19 who were admitted to Shizishan Fangcang Hospital were selected.Record the patients clinical symptoms,tongue and pulse diagnosis data,analyze and summarize the characteristics of TCM syndromes of patients with COVID-19.Results Among 1200 cases of COVID-19 in Chongqing,874 cases (72.83%) were asymptomatic and 326 cases (27.17%) were mild.The top five TCM symptoms of mild patients were cough in 208 cases (63.80%),dry throat in 194 cases (59.51%),sore throat in 168 cases (51.53%),anorexia in 114 cases (34.97%),and fever in 91 cases (27.91%).Fever body temperature is mainly low fever.Among mild patients,248 cases (76.07%) had red tongue and 196 cases (60.12%) had white greasy coating.In asymptomatic patients,769 cases (87.99%) had light red tongue and 578 cases (66.13%) had thin yellow fur.168 cases (51.53%) of mild patients had slippery pulse,and 536 cases (61.33%) of asymptomatic patients had slippery pulse.Conclusion This round of COVID-19 in Chongqing is mainly asymptomatic and mild patients,which conforms to the clinical characteristics of “damp and warm disease” of “epidemic disease” in Chinese medicine,and its pathogenesis is characterized by “epidemic toxin carrying dampness”.

参考文献/References:

[1]Organization WH.Classification of omicron（B.1.1.529）：SARS-CoV-2 variant of concern［EB/OL］.（2021-12-31）［2022-12-18］.https：//www.who.int/news/item/26- 11- 2021-classificationof-Omicron-（B.1.1.529）-sars-cov-2-variant-of-concern.
[2]Christensen PA.Signals of significantly increased vaccine breakthrough,decreased hospitalization rates,and less severe disease in patients with coronavirus disease 2019 caused by the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston,texas[J].The American Journal of Pathology,2022,192(4):642-652.
[3]Menni C.Symptom prevalence,duration,and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of Omicron and delta variant dominance:a prospective observational study from the ZOE COVID Study[J].The Lancet,2022,399(10335):1618-1624.
[4]Xu XR.Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking[J].Journal of Integrative Medicine,2022,20(6):561-574.
[5]国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].（2022-03-15)\[2022-03-15］.http://www.nhe.gov.cn/yzygj/s7653p/202203/b74adelba 4494583805a3d2e40093d88/6les/ef09aa4070244620b010 951b088b8a27.pdf.
[6]Kozlov M.Omicron's feeble attack on the Lungs could make it less dangerous[J].Nature,2022,601(7892):177.
[7]Brandal LT,MacDonald E,Veneti L,et al.Outbreak caused by the SARS-CoV-2 Omicron variant in Norway,November to December 2021[J].Eurosurveillance,2021,26(50):2101147.
[8]徐湘茹,孙鼎,曹敏,等.上海市4264例无症状及轻型新冠病毒感染者临床特征及预后转归分析[J].中华危重病急救医学,2022(5):449-453.
[9]方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册[M].北京:人民卫生出版社,2020:24-27.
[10]方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用[J].陕西中医药大学学报,2022,45(3):1-4.
[11]Zhou S.Traditional Chinese medicine Shenhuang Granule in patients with severe/critical COVID-19:a randomized controlled multicenter trial[J].Phytomedicine,2021,89:153612.
[12]Wu XX,Zhou S,Liu CY,et al.Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients:a multicenter retrospective cohort study[J].Medicine,2021,100(40):e27410.
[13]方邦江,邬鑫鑫,张文,等.基于中医疫病理论之“表里双解”截断扭转法治疗新冠肺炎的理论与实践[J].陕西中医药大学学报,2022,45(4):1-7.
[14]方邦江,周爽.国医大师朱良春治疗疑难危急重症经验集[M].北京:中国中医药出版社,2013:80-88.
[15]方邦江,苏红,赵软金,等.新型冠状病毒奥密克戎变异株感染中医药防治专家共识[J].中国急救医学,2022,42(4):277-280.
[16]涂佳.浅谈温病特色诊法之舌诊[J].中国民间疗法,2021,29(10):22-24.
[17]周爽,卜建宏,孙丽华.方邦江治疗急重疑难病证学术经验[M].北京:中国中医药出版社,2018.
[18]戚亚婷,张玉峰,张依,等.急性胰腺炎中医治疗研究进展[J].中国中医药现代远程教育,2020,18(24):145-147.
[19]许禄华,黄小靖,李彦荣,等.基于 “温病在下其郁热” 探究大黄在新型冠状病毒肺炎的作用及潜在机制[J].中药药理与临床,2020,36(2):85-90.
[20]李雅莉,徐红日,曹鸿云,等.从免疫炎性损伤角度探讨5种清热解毒药物抗流感的机制及其临床意义[J].中国中医急症,2020,29(2):189-192,205.
[21]林思,秦慧真,邓玲玉,等.虎杖苷药理作用及机制研究进展[J].中国实验方剂学杂志,2021,27(22):241-250.

相似文献/References:

[1]周静 张念志 陈晶晶 李允栋 朱笑笑 李晶 汪诗清 汪媛媛李文霞陈蕾朱晓凯.回顾性分析安徽地区新型冠状病毒肺炎的中医药防治特点[J].陕西中医药大学学报,2022,(01):001.[doi:10.13424/j.cnki.jsctcm.2022.01.001]
[2]廖金花?王兴?凌利?彭双凤?田鑫?李林.从足厥阴肝经论治核酸难以转阴的新型冠状病毒肺炎[J].陕西中医药大学学报,2022,(01):006.[doi:10.13424/j.cnki.jsctcm.2022.01.002]
[3]何伟 胡勇 张惜燕 佟雅婧.从新型冠状病毒肺炎防治探讨中医疫病研究的关键问题[J].陕西中医药大学学报,2022,(02):001.[doi:10.13424/j.cnki.jsctcm.2022.02.001]
　HE Wei HU Yong ZHANG Xiyan TONG Yajing.Discussion on Key Issues in Study of TCM Epidemic Diseases from COVID-19 Prevention and Treatment[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):001.[doi:10.13424/j.cnki.jsctcm.2022.02.001]
[4]刘丽静 邓鑫 许克祥.中医药防治新冠肺炎的路径与现状分析[J].陕西中医药大学学报,2022,(02):007.[doi:10.13424/j.cnki.jsctcm.2022.02.002]
　LIU Lijing DENG Xin XU Kexiang.Path and Current Situation Analysis of COVID-19 Prevention and Treatment by TCM[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):007.[doi:10.13424/j.cnki.jsctcm.2022.02.002]
[5]李敏 王斌 高峰 欧莉 陈丹丹 董泰玮 刘阿萍 张冰.中医药防治新型冠状病毒肺炎背景下《中药学》芳香化湿类药课程设计的思考[J].陕西中医药大学学报,2022,(02):123.[doi:10.13424/j.cnki.jsctcm.2022.02.027]
[6]罗庭苇 何成诗.基于系统解剖学浅析新冠肺炎中医病因[J].陕西中医药大学学报,2022,(04):013.[doi:10.13424/j.cnki.jsctcm.2022.04.003]
[7]王东军 张颖 焦锟关媛媛 田之魁 孙璇 田春颖 步怀恩 赵铁牛 王泓午.新冠疫情视域下中医预防医学人才培养刍议[J].陕西中医药大学学报,2022,(04):144.[doi:10.13424/j.cnki.jsctcm.2022.04.030]
　WANG Dongjun ZHANG Ying JIAO Kun GUAN Yuanyuan TIAN Zhikui SUN Xuan TIAN Chunying BU Huaien ZHAO Tieniu WANG Hongwu.Discussion on Talents Training of TCM Preventive Medicine from Perspective of COVID-19[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):144.[doi:10.13424/j.cnki.jsctcm.2022.04.030]
[8]刘海涛方邦江 韩正贵刘力 张贵民褚亚军 徐湘茹 张文 涂雅丹7.海南省三亚市72例新型冠状病毒肺炎中医证候特点及治疗策略[J].陕西中医药大学学报,2023,(01):001.[doi:2096-1340(2023)01-0001-05]

备注/Memo

备注/Memo:
基金项目：国家重点研发计划项目(2018YFC1705900)；国家中医药管理局 2022 年第五批新型冠状病毒感染肺炎中医药应急专项课题(2022ZYLCYJ05-4)；上海中医药大学 2022 年度应对奥密克戎感染新型冠状病毒(2022YJ-03，2022YJ-06)；重庆市教委科学技术研究计划项目（KJZD-K202215103）；成都中医药大学2021年度“杏林学者”医院专项（YYZX2021065）；成都中医药大学2021年度教育教学改革项目(JGJD2021024)
更新日期/Last Update: 2023-03-27